ASGCT, NORD Partner for Free Educational Gene Therapy Webinars

ASGCT Staff - August 19, 2019

ASGCT and the National Organization for Rare Disorders are partnering for a five-part educational webinar series designed to inform patients, patient advocates, families, and the public about the history and potential of gene therapies.

The first of those free webinars, "Gene Therapy: Yesterday, Today and Tomorrow," will be held on August 29 at noon EST. Two longtime ASGCT members are scheduled to speak on the ongoing development of gene therapies:

  • Cenk Sumen, Ph.D.: Chief technology officer at Stemson Therapeutics and former chair of the ASGCT Outreach and Communications Committee
  • Phillip Tai, Ph.D.: Instructor at the University of Massachusetts Medical School and current chair of the ASGCT Outreach and Communications Committee

Register for Free to Attend Gene Therapy: Yesterday, Today and Tomorrow

NORD Senior Program Manager Katie Kowalski is also scheduled to speak as part of the webinar.

"Gene Therapy: Yesterday, Today and Tomorrow" is the first free educational webinar in a five-part collaboration between ASGCT and NORD. Join us on August 29 for this event and mark your calendar for four more events before the end of 2019:

  • The Science Behind Gene Therapy – Wednesday, September 25
  • The FDA’s Role in Gene Therapy – Wednesday, October 30
  • Understanding the Gene Therapy Process and Aftercare – Wednesday, November 20
  • Life After Gene Therapy – Wednesday, December 18
ASGCT Policy Summit
November 4 – 6 | Washington D.C.